DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Pluristem Therapeutics, Inc. (PSTI)
« Back to company indexPSTI Chatter Timeline
Stock Ticker for PSTI
Most Active Tweeters for PSTI
| User | Tweets |
|---|---|
| @GantosJ | 4 |
| @stocksnotifyme | 3 |
| @greyzone513 | 2 |
| @TranscriptDaily | 2 |
| @Gambiste1 | 2 |
Recent Tweets for PSTI
 |
@stocknewstimes -$0.07 Earnings Per Share Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/4UvH8JModL July 15th 2019, 11:07am |
 |
@TranscriptDaily Pluristem Therapeutics $PSTI Lifted to Hold at Zacks Investment Research https://t.co/XOwPp3jB23 July 14th 2019, 7:07am |
 |
@TheMarketsDaily Pluristem Therapeutics $PSTI Lifted to Hold at Zacks Investment Research https://t.co/InMoMUAU0m July 14th 2019, 7:07am |
 |
@StockSpotter $PSTI up 2.4% to 0.56 since our bullish setup notification on Thu. Jul 11 #swingtrading https://t.co/jdxhy2BbEc July 12th 2019, 10:07am |
 |
@dispatchtribune Pluristem Therapeutics $PSTI Raised to Hold at Zacks Investment Research https://t.co/WUwu9KsFUm July 11th 2019, 10:07pm |
 |
@EnterpriseLeade Pluristem Therapeutics $PSTI Upgraded by Zacks Investment Research to Hold https://t.co/k1KtcoJZAP July 11th 2019, 10:07pm |
 |
@registrarjourn Pluristem Therapeutics $PSTI Upgraded by Zacks Investment Research to Hold https://t.co/EncViLKf3b July 11th 2019, 10:07pm |
 |
@GantosJ @umnawong The near term catalyst for $PSTI is the #ARS clinical trial results by the DoD. The U.S. Department of D… https://t.co/Fv9Avhn3Ed July 11th 2019, 7:07am |
 |
@AmericanBanking -$0.07 EPS Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/bAF5VZUl9J #stocks July 10th 2019, 10:07pm |
|
@TranscriptDaily -$0.07 EPS Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/qpIcglvjLc July 10th 2019, 10:07pm |
 |
@greyzone513 @GantosJ $PSTI on sale for those who like buying cheap shares July 10th 2019, 6:07pm |
 |
@ChimeraResearch RT @GantosJ: Interesting interview with $PSTI CEO & the #ARS clinical trial with the DoD + NIH Regenerative Medicine Companies Pursue Uniqu… July 10th 2019, 10:07am |
|
@GantosJ Interesting interview with $PSTI CEO & the #ARS clinical trial with the DoD + NIH Regenerative Medicine Companies P… https://t.co/6G0H9Zr0U9 July 10th 2019, 9:07am |
|
@greyzone513 @humour_humourrr @ARKInvest $PSTI treatment for CLI could blow the doors off. Preliminary data is astounding and the market for CLI vast. July 9th 2019, 8:07am |
 |
@ConsumerFeed Pluristem Therapeutics $PSTI Downgraded to Sell at Zacks Investment Research https://t.co/tmuqmmq3an July 6th 2019, 3:07am |
 |
@WatchlistN Pluristem Therapeutics $PSTI Cut to Sell at Zacks Investment Research https://t.co/hPPF1DhYZz July 5th 2019, 7:07am |
 |
@ZolmaxNews Pluristem Therapeutics $PSTI Cut to Sell at Zacks Investment Research https://t.co/eyD9ZcZV4s July 5th 2019, 7:07am |
 |
@midetimes Pluristem Therapeutics $PSTI Downgraded by Zacks Investment Research to Sell https://t.co/kxN8HSbQLg #stocks July 5th 2019, 7:07am |
 |
@dailymailtimes Pluristem Therapeutics $PSTI Downgraded by Zacks Investment Research to Sell https://t.co/BfWiWhDRqt #investing July 5th 2019, 7:07am |
 |
@dailypoliticaln Pluristem Therapeutics $PSTI Downgraded by Zacks Investment Research to Sell https://t.co/P2e2qKXFbU July 5th 2019, 7:07am |
 |
@JoyfulTrades Golden_Cross: $PSTI Daily Chart https://t.co/qTP3vts2Mv July 4th 2019, 1:07pm |
 |
@Gambiste1 RT @GantosJ: $PSTI Compensation Committee, approved the reduction of the annual salary of its CEO, Chairman & directors, each by 25% from t… July 2nd 2019, 4:07pm |
 |
@Pluristem Yaky Yanay released his first shareholder letter as sole $PSTI CEO today, highlighting recent achievements and a co… https://t.co/babtw9dFsy July 2nd 2019, 12:07pm |
 |
@StockNewsNow $PSTI Pluristem Therapeutics’ CEO Issues Shareholder Letter https://t.co/9wsgulAhkf July 2nd 2019, 12:07pm |
 |
@marketexclusive $PSTI PLURISTEM THERAPEUTICS INC. (NASDAQ:PSTI) Files An 8-K Departure of Directors or Certain Officers; Election… https://t.co/np9KstrYXg July 2nd 2019, 11:07am |
 |
@DZalkowitz @BioStocks $PSTI maybe after a R/S July 2nd 2019, 9:07am |
 |
@Stock_News_Now $PSTI: New SEC Filing for PSTI: Form 8-K (No. 0001213900-19-011923): https://t.co/A5gBaO1yLg July 2nd 2019, 8:07am |
|
@GantosJ $PSTI Compensation Committee, approved the reduction of the annual salary of its CEO, Chairman & directors, each by… https://t.co/jWZYeiGYAP July 2nd 2019, 7:07am |
 |
@Traderideas1 RT @BioStocks: $PSTI initiated at Buy at B.Riley/FBR. PT $4.50 July 2nd 2019, 7:07am |
 |
@StockTexts $PSTI Pluristem Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/bc0g1ErFNi July 2nd 2019, 7:07am |
 |
@stocksnotifyme $PSTI PLURISTEM CEO SAYS BOARD APPROVED SALARY CUT FOR DIRECTORS 'CEO Suggests Own Salary Cut as ’Vote of Confidence’ July 2nd 2019, 7:07am |
 |
@fintel_io $PSTI / Pluristem Therapeutics files form 8-K https://t.co/1E0Z8XmS2A - Departure of Directors or Certain Officers;… https://t.co/N8m6IFESEG July 2nd 2019, 7:07am |
|
@GantosJ $PSTI Pluristem Therapeutics’ CEO Issues Shareholder Letter https://t.co/hcnocUGHRv https://t.co/mU3f589pBi July 2nd 2019, 7:07am |
 |
@FlashAlert_me $PSTI filed form 8-K on July 02, 07:06:33: Item5.02: Departure of Election 0f Officers or Compensatory Arrangements https://t.co/UD3zcF55Kf July 2nd 2019, 7:07am |
 |
@VisualStockRSRC $PSTI - Pluristem Therapeutics’ CEO Issues Shareholder Letter https://t.co/rFhXncns7S July 2nd 2019, 7:07am |
 |
@BioStocks $PSTI initiated at Buy at B.Riley/FBR. PT $4.50 July 2nd 2019, 6:07am |
|
@Gambiste1 RT @bthefirsttoknow: B.Riley/FBR Starts $PSTI at Buy PT $4.5 https://t.co/JGvPSSbjVC July 2nd 2019, 6:07am |
 |
@bthefirsttoknow B.Riley/FBR Starts $PSTI at Buy PT $4.5 https://t.co/JGvPSSbjVC July 2nd 2019, 5:07am |
|
@stocksnotifyme B.Riley/FBR Starts Pluristem Therapeutics $PSTI at Buy PT $4.5 July 2nd 2019, 5:07am |
|
@stocksnotifyme B.RILEY/FBR STARTS $PSTI AT BUY July 2nd 2019, 5:07am |
 |
@WKRBNews Pluristem Therapeutics $PSTI Lifted to “Hold” at Zacks Investment Research https://t.co/fSyn36z2xW #markets June 29th 2019, 2:06am |
|
@ZolmaxNews Pluristem Therapeutics $PSTI Lifted to “Hold” at Zacks Investment Research https://t.co/Y12TYIGtfM June 29th 2019, 2:06am |
|
@ConsumerFeed Pluristem Therapeutics $PSTI Upgraded to Hold by Zacks Investment Research https://t.co/wc9aMnRdqE June 28th 2019, 7:06am |
 |
@ThisLincolnian Pluristem Therapeutics $PSTI Stock Rating Upgraded by Zacks Investment Research https://t.co/Ercvx6SOzJ June 27th 2019, 2:06am |
 |
@TickerReport Pluristem Therapeutics $PSTI Lifted to Hold at Zacks Investment Research https://t.co/mLieQAXQzL June 27th 2019, 2:06am |
 |
@etkoinc $psti its time to treat with stam cells that are safe. time for the FDA to clear psti cells!!!https://t.co/AOd0iTGeDV June 26th 2019, 11:06am |
|
@etkoinc RT @shmulic12: $PSTI - A positive trend can be above MA50 0.62 - #PSTI chart https://t.co/Z4WYcS8aZq June 26th 2019, 11:06am |
 |
@shmulic12 $PSTI - A positive trend can be above MA50 0.62 - #PSTI chart https://t.co/Z4WYcS8aZq June 26th 2019, 9:06am |
|
@ThisLincolnian Pluristem Therapeutics $PSTI & Gritstone Oncology $GRTS Head to Head Review https://t.co/glP3DnuxFg June 26th 2019, 4:06am |
 |
@bbnsnews Pluristem Therapeutics $PSTI & Gritstone Oncology $GRTS Head to Head Review https://t.co/wQXJ6SJl07 June 26th 2019, 4:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.